Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 9/20 | 0.43 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 8/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3083561 | 1.00 | L3MBTL1 (0.47) | L3MBTL1LMNAMAPK1HTTMEN1 | |
| SCHEMBL3071597 | 0.87 | KMT2A (0.49) | L3MBTL1LMNAMAPK1HTTMEN1 | |
| SCHEMBL3071599 | 0.87 | KMT2A (0.49) | L3MBTL1LMNAMAPK1HTTMEN1 | |
| SCHEMBL3088344 | 0.86 | KDM4C (0.48) | L3MBTL1LMNAMEN1KMT2APPARA | |
| SCHEMBL3088343 | 0.86 | KDM4C (0.48) | L3MBTL1LMNAMEN1KMT2APPARA | |
| SCHEMBL8308833 | 0.84 | PPARG (0.48) | L3MBTL1MEN1KMT2AKDM4CPPARG | |
| SCHEMBL8307747 | 0.84 | MEN1 (0.39) | L3MBTL1LMNAMEN1KMT2AKDM4C | |
| SCHEMBL29761180 | 0.81 | LMNA (0.42) | L3MBTL1LMNAMAPK1HTTMEN1 | |
| SCHEMBL3071803 | 0.81 | MAPT (0.43) | L3MBTL1LMNAHTTMEN1KMT2A | |
| SCHEMBL3071801 | 0.81 | MAPT (0.43) | L3MBTL1LMNAHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100226875-A1 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2010-09-09 | — | — | US | claimed |
| US-20100226875-A1 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100226875-A1 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES | HPD, TRHDE, BPHL | L3MBTL1 2236/4885LMNA 3571/4885MAPK1 4412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.